Results The primary composite outcome improved by 63.5 percentage points in the L-Carnitine-combination group vs
Serious reactions are rare but can include rash, wheezing, trouble breathing, or swelling of the face or throat
After 8 weeks of citalopram or escitalopram treatment in MDD patients, the levels of three short-chain acylcarnitines (C3:0, C4:0, and C5:0) increased, and the medium-chain and long-chain acylcarnitines (C8:0, C10:0, C12:0, C14:2, C16:0, C16:1, C18:0, C18:1, and C18:2) decreased (37)
Vitamin A deficiency will most commonly present with visual disturbances
Skin care isn't a one-size-fits-all kind of deal
High mobility group box 1 mediates TMAO-induced endothelial dysfunction